This article provides a detailed exploration of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling as a cornerstone of modern oncology drug development and personalized treatment.
This article provides a comprehensive guide for researchers and drug development professionals on integrating automated liquid handling (ALH) into digital PCR (dPCR) workflows.
The analysis of circulating tumor DNA (ctDNA) through liquid biopsy has transformed oncology, enabling non-invasive cancer monitoring, therapy response assessment, and minimal residual disease detection.
This article provides a comprehensive guide for researchers and drug development professionals seeking to enhance the precision of copy number quantification.
This article provides a critical analysis of how freeze-thaw cycles impact circulating tumor DNA (ctDNA) integrity, a paramount pre-analytical variable in liquid biopsy.
Digital PCR (dPCR) has emerged as a powerful tool for the detection of circulating tumor DNA (ctDNA), enabling non-invasive monitoring of treatment response, minimal residual disease (MRD), and resistance mutations...
This article provides a comprehensive guide for researchers and drug development professionals on minimizing false positive signals in digital PCR (dPCR) for circulating tumor DNA (ctDNA) analysis.
This article provides a comprehensive analysis of the impact of restriction enzymes on the precision and accuracy of digital PCR (dPCR) for researchers and drug development professionals.
This article provides a comprehensive overview of circulating tumor DNA (ctDNA) for minimal residual disease (MRD) detection, a transformative approach in oncology.
This article provides a detailed framework for researchers and scientists troubleshooting the critical challenge of no amplification events in digital PCR (dPCR) assays for circulating tumor DNA (ctDNA).